Table 6.
Compounds | CLogPa | ACD/LogPb | LogD7.40b | MIC (μM)c | |
---|---|---|---|---|---|
MRSA G31 | MRSA G47 | ||||
55 | 5.58 | 6.52 | 6.33 | 14.7 | 7.4 |
56 | 7.58 | 8.76 | 8.70 | 12.0 | 6.0 |
57 | 3.78 | 4.72 | 4.51 | 16.2 | 32.3 |
58 | 5.53 | 6.52 | 6.33 | 14.7 | 14.7 |
59 | 4.94 | 5.89 | 5.67 | 28.4 | 7.1 |
60 | 4.99 | 5.89 | 5.68 | 28.4 | 14.2 |
61 | 5.71 | 6.60 | 6.35 | 29.4 | 14.7 |
62 | 4.86 | 5.81 | 5.62 | 28.4 | 28.4 |
63 | 4.81 | 5.81 | 5.62 | 28.4 | 28.4 |
64 | 3.68 | 4.56 | 4.37 | 35.1 | 35.1 |
65 | 6.25 | 7.24 | 7.06 | 122.4d | 122.4d |
66 | 2.44 | 3.19 | 2.96 | 1469.2 | 734.6 |
aThe CLogP values were calculated using software ChemBioDraw Ultra 12.0.
bThe ACD/Log P and LogD7.40 values were calculated using software ACD/Labs 6.0.
cMIC, minimum inhibitory concentration; MRSA G31 and G47, methicillin-resistant Staphylococcus aureus G31 and G47.
dBoth MICs of compound 65 against MRSA G31 and G47 were more than 25 μg/mL (61.2 μM). As microdilution broth method was used to test MIC, we set 50 μg/mL (122.4 μM) as their MICs.